Bruker (BRKR) Asset Writedowns and Impairment (2010 - 2026)

Bruker (BRKR) has reported Asset Writedowns and Impairment for 14 consecutive years, with $4.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Asset Writedowns and Impairment fell 39.71% year-over-year to $4.1 million; the trailing twelve-month figure through Jun 2026 stood at $139.4 million (up 133.5% YoY), and the FY2025 full-year result was $152.3 million, up 152.99% from the prior year.
• Asset Writedowns and Impairment retreated to $4.1 million in Q2 2026 per BRKR's latest filing, from $4.8 million in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $123.7 million in Q3 2025 and bottomed at -$1.9 million in Q3 2022.
• Historically, Asset Writedowns and Impairment has averaged $15.4 million across 5 years, with a median of $4.4 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Asset Writedowns and Impairment soared 11500.0% in 2023, then slumped 85.32% in 2025.
• Over 5 years, Asset Writedowns and Impairment stood at $1.6 million in 2022, then soared by 68.75% to $2.7 million in 2023, then soared by 1111.11% to $32.7 million in 2024, then plunged by 85.32% to $4.8 million in 2025, then dropped by 14.58% to $4.1 million in 2026.
• According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $4.1 million, $4.8 million, and $123.7 million for Q2 2026, Q4 2025, and Q3 2025 respectively.